• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Glen James, PhD

Latest:

Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 Diabetes

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.


Nicole Beagin

Latest:

AJMCtv® Interviews, February 2017

AJMCtv® interviews let you catch up with experts in healthcare. Topics include challenges with immuno-oncology, including the patient voice in treatment decisions, and why payers should cover genomic testing.


Jonathan Wesley Riess, MD, MS

Latest:

Advancing Care and Future Impact of NCCN Updates in ROS1+ NSCLC

An expert discusses key challenges in advancing care for ROS1-positive non-small cell lung cancer, including the rarity of the disease and difficulty enrolling patients in clinical trials, while highlighting the importance of access to next-generation therapies, the impact of updated 2025 NCCN guidelines recommending taletrectinib, and the critical need for timely, comprehensive molecular testing to guide targeted treatment and avoid ineffective immunotherapy.


Bianka Ditscheid, PhD

Latest:

Clinical and Economic Outcomes of a Collaborative Cardiology Care Program

Patients with chronic cardiac conditions benefited from a health care program that strengthened collaboration between general practitioners and cardiology specialists in Baden-Wuerttemberg, Germany.


Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC

Latest:

Challenges with Undertreatment in Hyperlipidemia and Opportunities to Address this Gap

Panelists discuss how: clinical inertia, patient apathy, and the asymptomatic nature of high cholesterol all contribute to undertreatment and poor outcomes.


Steven McCarus, MD, FACOG

Latest:

Defining Value Among Treatment Options

Payer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.


Sarfaraz K. Niazi, PhD

Latest:

Contributor: COVID-19 Vaccine May Not Be the Ultimate Panacea

We should look forward to a safe, effective vaccine for coronavirus disease 2019 (COVID-19) but not expect it to be the ultimate panacea.


Timothy Aungst, PharmD

Latest:

Final Thoughts on Arrhythmia Management

Experts agree that developing value-based care models for atrial fibrillation requires collaborative, data-driven strategies—leveraging clinical pharmacists for personalized medication management and prioritizing stroke prevention and rhythm control—while embracing innovation and workforce redesign to balance quality, cost-effectiveness, and avoid overdiagnosis in an evolving health care landscape.


Shu-Wen Su, PhD

Latest:

Patient Value Co-creation Behavior Scale Based on the DART Model

This study aimed to develop and evaluate the psychometric properties of a scale measuring patient value co-creation behavior based on the DART (Dialogue, Access, Risk assessment, Transparency) model.


Juliane Hafermann, PhD

Latest:

Clinical Outcomes in Heart Failure Monitoring: A Pooled Rates Analysis

This systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge.


Gunnar Gunnarsson, MS

Latest:

The Unintended Consequences of Medicare’s Wage Index Adjustment on Device-Intensive Hospital Procedures

The authors found an association between Medicare’s wage index adjustment and the differential use of labor-intensive surgical procedures and medical device–intensive minimally invasive clinical procedures across the United States.


Nicholas Wrigley

Latest:

NACT Use Appears to Be Increasing in Less Common Epithelial Ovarian Cancers

Patients with low-grade serous ovarian cancer appear to have worse survival outcomes following treatment with neoadjuvant chemotherapy (NACT).


Christine Iannaccone, MPH

Latest:

A Machine Learning Technology for Addressing Medication-Related Risk in Older, Multimorbid Patients

A novel machine learning system effectively stratifies emergency department use and hospitalization risk of older patients with multimorbidity who take multiple medications and provides appropriate medication recommendations.


Jamie L. Fierstein, PhD

Latest:

Guideline-Informed Care Among Medicaid-Enrolled Children With Food Allergy

This article describes food allergy–related service utilization and identifies factors associated with guideline-informed care among Medicaid-enrolled US children with food allergy.


Emanuel Lucas, MPH

Latest:

Reduced Medical Spending Associated With Integrated Pharmacy Benefits

Members covered by an integrated pharmacy benefit (as opposed to a pharmacy carve-out) experienced slower growth in medical spending.


Ronald Brooks, MD

Latest:

Telemedicine Catches On: Changes in the Utilization of Telemedicine Services During the COVID-19 Pandemic

This analysis of health insurance claims data demonstrates rapid increase and sustained high utilization of telemedicine services during the COVID-19 pandemic.


Michael J. Maniaci, MD

Latest:

Bridging Boundaries: A Research Consortium to Advance Hospital-at-Home Care Delivery

As the hospital-at-home model grows, a consortium is needed to advance scalability, equity, caregiver well-being, and cost efficiency through research and collaboration.


Nicholas G. Anderson, MD

Latest:

Unmet Needs in the Treatment of Wet AMD

Nicholas G. Anderson, MD; Philip Niles, MD, MBA; Kevin U. Stephens, Sr., JD, MD; and Jim Kenney, RPh, MBA, provide insight on unmet needs and future directions for the treatment of wet AMD and DME.


Sara B. Nugent, PhD, RN

Latest:

An Assessment of Nurse Practitioner Low-Value Care Use in Primary Care

Primary care nurse practitioners were found to use low-value care at lower or relatively similar rates compared with the general clinician population.


Mark Cole, BS

Latest:

Long-Term Health Care Costs Following COVID-19: Implications for Pandemic Preparedness

A difference-in-differences analysis of health care claims data evaluated excess health care costs in the 12 months following COVID-19 diagnosis among the general and older adult populations.


Alexander Ding, MD, MBA

Latest:

Contributor: Roadmap to the Quadruple Aim—A Framework for Minimizing Physician Burnout During the Transition to Value-Based Care

As provider and payer organizations pursue the Quadruple Aim, it is important that they take into account not just the contracting but also the transformation in staffing, clinical workflows, and culture as these organizations evolve.


Jean S. Kutner, MD, MSPH

Latest:

Modeling of an Alternative Reimbursement Method for Palliative Care

The authors modeled a version of the Patient and Caregiver Support for Serious Illness alternative reimbursement structure for palliative care using data from the Statin Trial.


Malena Mahendran, MSc

Latest:

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.


Anthony T. Lo Sasso, PhD

Latest:

The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks future investment in research and development.


Jessica K. Costales-Cantrell, DO, MBS

Latest:

Antibiotic Practice Patterns With Procalcitonin Levels in Patients With Acute Lower Respiratory Tract Infection

Although clinical trials have demonstrated the utility of procalcitonin (PCT) testing and potential benefit on antibiotic stewardship, findings suggest that clinicians do not order PCT testing with regularity and also prioritize clinical judgment over PCT results.



Nadine Hertel, MBA

Latest:

Cost-effectiveness of Nivolumab in Patients With NSCLC in the United States

This article presents a cost-effectiveness analysis of nivolumab vs docetaxel from the US payer perspective in non–small cell lung cancer (NSCLC) based on randomized phase 3 studies with a minimum 5 years of follow-up.



Kimberly A. Dulaney, MD

Latest:

A “Sludge Audit” for Health System Colorectal Cancer Screening Services

A systematic, mixed methods “sludge audit” identified novel health system delivery targets for improving colorectal cancer screening services.


David M. Jacobs, PharmD, PhD

Latest:

Pharmacists and Transitions of Care From Emergency Department to Home

Pharmacists’ roles in transitions of care continue to evolve. Evaluation of pharmacist-led interventions as patients transition from emergency department to home is needed.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.